phentolamine has been researched along with Ischemia in 63 studies
Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
Excerpt | Relevance | Reference |
---|---|---|
" Fortunately, digital ischemia can be reversed with phentolamine." | 9.12 | Phentolamine Rescue for Digital Ischemia Following Lidocaine with Epinephrine Local Anesthesia: Case Presentation, Review of the Literature and Treatment Options. ( Hewitt, C; Smith, VJ; Van Demark, RE, 2021) |
"Labetalol was found to be less effective in preventing tissue necrosis." | 5.28 | Treatment of peripheral ischemia secondary to lidocaine containing epinephrine. ( Aycock, BG; Hawtof, DB; Moody, SB, 1989) |
" A total of 400 patients with erectile dysfunction were evaluated before and after diagnostic intracavernous injection of a trimix solution (papaverine+phentolamine+PGE1) using color Doppler sonography." | 5.11 | The value of penile duplex in the prediction of intracavernous drug-induced priapism. ( Ghanem, HM; Kamel, II; Mousa, AA; Salem, A; Shamloul, R, 2004) |
" This selective localization of Annexin A5 was reduced by ischemic preconditioning (10 minutes of ischemia plus reperfusion before ischemic exercise) or by infusion of adenosine into the brachial artery to 6+/-1% and 10+/-3%, respectively (P<0." | 3.73 | Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. ( Boerman, OC; Oyen, WJ; Ramakers, BP; Riksen, NP; Rongen, GA; Smits, P; Steinmetz, N, 2005) |
" Phentolamine-induced hypotension (MABP of 55 +/- 4 mmHg) in normoxia lowered Pm(O(2)) to 26 +/- 6 Torr but did not increase LEA." | 3.72 | Dissociation between skeletal muscle microvascular PO2 and hypoxia-induced microvascular inflammation. ( Allen, J; Gonzalez, NC; Shah, S; Wood, JG, 2003) |
" Treatment consisted of administration of subcutaneous phentolamine into the area of ischemia approximately 6 hours after the injury occurred." | 3.67 | Acute management of dopamine infiltration injury with Regitine. ( Sadove, AM; Siwy, BK, 1987) |
"Phentolamine infusion was associated with increased epileptiform transient activity and a greater fall in cerebral oxygenation in the early post-HI recovery phase." | 1.91 | Alpha-adrenergic receptor activation after fetal hypoxia-ischaemia suppresses transient epileptiform activity and limits loss of oligodendrocytes and hippocampal neurons. ( Bennet, L; Davidson, JO; Dhillon, SK; Gunn, AJ; Gunn, ER; Lear, CA; Pedersen, MV; Wassink, G, 2023) |
"Here, mice subjected to renal ischemia reperfusion injury had significantly lower levels of renalase in the plasma and kidney compared with sham-operated mice." | 1.39 | Renalase protects against ischemic AKI. ( Baroni, S; D'Agati, VD; Desir, GV; Kim, JY; Kim, M; Lee, HT; Tang, L; Wang, P, 2013) |
"Phentolamine is a readily available treatment, which is easily and safely given in the emergency setting." | 1.33 | Adrenaline-induced digital ischaemia reversed with phentolamine. ( Molony, D, 2006) |
"Labetalol was found to be less effective in preventing tissue necrosis." | 1.28 | Treatment of peripheral ischemia secondary to lidocaine containing epinephrine. ( Aycock, BG; Hawtof, DB; Moody, SB, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (44.44) | 18.7374 |
1990's | 13 (20.63) | 18.2507 |
2000's | 12 (19.05) | 29.6817 |
2010's | 5 (7.94) | 24.3611 |
2020's | 5 (7.94) | 2.80 |
Authors | Studies |
---|---|
Van Demark, RE | 1 |
Hewitt, C | 1 |
Smith, VJ | 1 |
Dhillon, SK | 1 |
Gunn, ER | 1 |
Pedersen, MV | 1 |
Lear, CA | 1 |
Wassink, G | 1 |
Davidson, JO | 1 |
Gunn, AJ | 1 |
Bennet, L | 1 |
Aljahany, MS | 1 |
Aleid, DK | 1 |
Aal Ibrahim, AM | 1 |
Rajiah, E | 1 |
McKean, AR | 1 |
Bain, C | 1 |
Gueffier, X | 1 |
Gueffier, E | 1 |
Yalom, A | 1 |
Jiang, Q | 1 |
Ding, S | 1 |
Wu, J | 1 |
Liu, X | 1 |
Wu, Z | 1 |
Zhu, AF | 1 |
Hood, BR | 1 |
Morris, MS | 1 |
Ozer, K | 1 |
Janssen, RL | 1 |
Roeleveld-Versteegh, AB | 1 |
Wessels-Basten, SJ | 1 |
Hendriks, T | 1 |
Taylor, JC | 1 |
Yang, HT | 1 |
Laughlin, MH | 1 |
Terjung, RL | 1 |
Sinclair, MD | 1 |
Bailey, MA | 1 |
McAree, BJ | 1 |
Dewhurst, D | 1 |
Kent, PJ | 1 |
Xu, J | 1 |
Holt, A | 1 |
Lee, HT | 1 |
Kim, JY | 1 |
Kim, M | 1 |
Wang, P | 1 |
Tang, L | 1 |
Baroni, S | 1 |
D'Agati, VD | 1 |
Desir, GV | 1 |
Shah, S | 1 |
Allen, J | 1 |
Wood, JG | 1 |
Gonzalez, NC | 1 |
Shamloul, R | 1 |
Ghanem, HM | 1 |
Salem, A | 1 |
Kamel, II | 1 |
Mousa, AA | 1 |
Rongen, GA | 1 |
Oyen, WJ | 1 |
Ramakers, BP | 1 |
Riksen, NP | 1 |
Boerman, OC | 1 |
Steinmetz, N | 1 |
Smits, P | 1 |
Molony, D | 1 |
Singh, T | 1 |
Randhawa, S | 1 |
Khanna, R | 1 |
Moradkhan, R | 1 |
McQuillan, P | 1 |
Hogeman, C | 1 |
Leuenberger, A | 1 |
Linton-Frazier, L | 1 |
Leuenberger, UA | 1 |
Krzymien, J | 1 |
Brenner, GM | 1 |
Hardy, SJ | 1 |
Agostini, DE | 1 |
Hinterberger, JW | 1 |
Kintzi, HE | 1 |
Barbieri, A | 2 |
Zonta, F | 2 |
Saracino, ML | 1 |
Dondi, G | 1 |
Frattini, P | 2 |
Lucchelli, A | 1 |
Santagostino, M | 1 |
D'Agostino, G | 1 |
Maestri, MO | 2 |
Zonta, A | 2 |
Dietz, NM | 1 |
Engelke, KA | 1 |
Samuel, TT | 1 |
Fix, RT | 1 |
Joyner, MJ | 1 |
Sylaidis, P | 1 |
Logan, A | 1 |
McGovern, SJ | 1 |
Murali, KS | 1 |
Nayeem, N | 1 |
Lee, G | 1 |
Thomas, PC | 1 |
Pettenazza, P | 1 |
Gaspari, A | 1 |
Richter, S | 1 |
Yamauchi, J | 1 |
Minor, T | 1 |
Menger, MD | 1 |
Vollmar, B | 1 |
Ko, WJ | 1 |
Chen, YS | 1 |
Tsai, PR | 1 |
Lee, PH | 1 |
Khairalla, E | 1 |
Michael, R | 1 |
Fam, F | 1 |
Abadir, A | 1 |
Francoual, M | 1 |
Lélek, I | 2 |
Ahlström, P | 1 |
Thalmann, I | 1 |
Thalmann, R | 1 |
Ise, I | 1 |
Munda, R | 1 |
Tyler, G | 1 |
Alexander, JW | 1 |
Lakey, WH | 1 |
Burrell, AR | 1 |
Spielman, WS | 1 |
Osswald, H | 1 |
Weber, TR | 1 |
Freier, DT | 1 |
Salles, CA | 1 |
Ramsburgh, SR | 1 |
Lindenauer, SM | 1 |
Bache, RJ | 1 |
Cobb, FR | 1 |
Ebert, PA | 1 |
Greenfield, JC | 1 |
McCauley, WA | 1 |
Gerace, RV | 1 |
Scilley, C | 1 |
Maguire, WM | 1 |
Reisdorff, EJ | 1 |
Smith, D | 1 |
Wiegenstein, JG | 1 |
Forrest, CR | 1 |
Pang, CY | 1 |
Zhong, AG | 1 |
Neligan, PC | 1 |
Roberts, JR | 1 |
Krisanda, TJ | 1 |
Aycock, BG | 1 |
Hawtof, DB | 1 |
Moody, SB | 1 |
Haugan, A | 1 |
Kirkebø, A | 1 |
Siwy, BK | 1 |
Sadove, AM | 1 |
Richards, RR | 1 |
Seaber, AV | 1 |
Urbaniak, JR | 1 |
Majid, PA | 1 |
Sharma, B | 1 |
Taylor, SH | 1 |
Hinshaw, LB | 1 |
Page, BB | 1 |
Brake, CM | 1 |
Emerson, TE | 1 |
Somogyi, A | 1 |
Selye, H | 1 |
Grandchamp, A | 1 |
Ayer, G | 1 |
Truniger, B | 1 |
Ekelund, L | 1 |
Göthlin, J | 1 |
Olin, T | 1 |
Váczy, L | 1 |
Lenner, A | 1 |
Molnár, A | 1 |
Toledo-Pereyra, LH | 1 |
Moberg, AW | 1 |
Najarian, JS | 1 |
Guy, JM | 1 |
Davies, RL | 1 |
McLachlan, MS | 1 |
Evans, KT | 1 |
Zelis, R | 1 |
Longhurst, J | 1 |
Capone, RJ | 1 |
Mason, DT | 1 |
Cortesini, C | 1 |
Novelli, GP | 1 |
Bertini, D | 1 |
Cappelli, G | 1 |
Francini, R | 1 |
Pagliai, P | 1 |
Pagni, E | 1 |
Perna, AM | 1 |
Epstein, M | 1 |
Berk, DP | 1 |
Hollenberg, NK | 1 |
Adams, DF | 1 |
Chalmers, TC | 1 |
Abrams, HL | 1 |
Merrill, JP | 1 |
Weeks, PM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Caffeine Reduces Acute Ischemic Preconditioning[NCT00184912] | 24 participants | Interventional | 2003-09-30 | Completed | |||
The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy. A Double Blind Placebo- Controlled Cross-over Study in Subjects With the Metabolic Syndrome[NCT00405015] | Phase 2 | 13 participants (Actual) | Interventional | 2007-04-30 | Completed | ||
Opioid Induced Acute Preconditioning[NCT00184938] | 40 participants (Anticipated) | Interventional | 2005-01-31 | Suspended | |||
Does Rosuvastatin Reduce Ischemia/Reperfusion Injury in Humans In-Vivo? A Randomized Double Blind Placebo Controlled Trial[NCT00315510] | Phase 2 | 20 participants | Interventional | 2006-04-30 | Completed | ||
Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?[NCT00430170] | Phase 4 | 20 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?[NCT00441597] | Phase 4 | 30 participants (Anticipated) | Interventional | 2007-02-28 | Completed | ||
Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise[NCT00441714] | 0 participants (Actual) | Interventional | 2007-10-31 | Withdrawn (stopped due to new insights have let us to expect marginal annexin targeting with a 10 minutes delay between reperfusion and administration of Annexin A5) | |||
Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?[NCT00457652] | Phase 4 | 24 participants (Actual) | Interventional | 2007-06-30 | Completed | ||
Pilot Study for the Development of Transient Forearm Endothelial Dysfunction[NCT00453531] | Phase 1/Phase 2 | 6 participants (Actual) | Interventional | 2007-03-26 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for phentolamine and Ischemia
Article | Year |
---|---|
Phentolamine Rescue for Digital Ischemia Following Lidocaine with Epinephrine Local Anesthesia: Case Presentation, Review of the Literature and Treatment Options.
Topics: Anesthesia, Local; Epinephrine; Humans; Ischemia; Lidocaine; Phentolamine | 2021 |
Phentolamine reversal of epinephrine-induced digital vasospasm. How to save an ischemic finger.
Topics: Accidents; Adolescent; Epinephrine; Female; Fingers; Humans; Ischemia; Needlestick Injuries; Phentol | 1994 |
3 trials available for phentolamine and Ischemia
Article | Year |
---|---|
The value of penile duplex in the prediction of intracavernous drug-induced priapism.
Topics: Alprostadil; Antihypertensive Agents; Erectile Dysfunction; Humans; Ischemia; Male; Middle Aged; Pap | 2004 |
Metabolic forearm vasodilation is enhanced following Bier block with phentolamine.
Topics: Adrenergic alpha-Antagonists; Adult; Autonomic Nerve Block; Blood Flow Velocity; Blood Pressure; Blo | 2007 |
Evidence for nitric oxide-mediated sympathetic forearm vasodiolatation in humans.
Topics: Adrenergic Agents; Adrenergic alpha-Antagonists; Adult; Bretylium Tosylate; Enzyme Inhibitors; Exerc | 1997 |
58 other studies available for phentolamine and Ischemia
Article | Year |
---|---|
Alpha-adrenergic receptor activation after fetal hypoxia-ischaemia suppresses transient epileptiform activity and limits loss of oligodendrocytes and hippocampal neurons.
Topics: Adrenergic Agents; Animals; Female; Fetal Hypoxia; Hippocampus; Humans; Hypoxia; Hypoxia-Ischemia, B | 2023 |
Reversal of Digital Ischemia with Phentolamine After Accidental Epinephrine Injection.
Topics: Adult; Epinephrine; Female; Finger Injuries; Humans; Injections; Ischemia; Needlestick Injuries; Phe | 2020 |
Accidental adrenaline auto-injector-induced digital ischaemia: a proposed treatment algorithm.
Topics: Adult; Algorithms; Epinephrine; Humans; Ischemia; Lidocaine; Male; Phentolamine | 2021 |
Digital ischemia under WALANT phentolamine reversed for patient with Raynaud phenomenon.
Topics: Fingers; Humans; Ischemia; Phentolamine; Raynaud Disease | 2021 |
Norepinephrine stimulates mobilization of endothelial progenitor cells after limb ischemia.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-2 Receptor Antagonists; Ani | 2014 |
Delayed-Onset Digital Ischemia After Local Anesthetic With Epinephrine Injection Requiring Phentolamine Reversal.
Topics: Aged; Anesthetics, Local; Antihypertensive Agents; Carpal Tunnel Syndrome; Epinephrine; Female; Fing | 2017 |
[Auto-injection with epinephrine in the finger of a 5-year-old child].
Topics: Child, Preschool; Epinephrine; Fingers; Food Hypersensitivity; Humans; Injections, Subcutaneous; Isc | 2008 |
Alpha-adrenergic and neuropeptide Y Y1 receptor control of collateral circuit conductance: influence of exercise training.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Arginine; Blood Pre | 2008 |
Images in vascular medicine: rapid epinephrine 'reversal' with phentolamine following accidental autoinjector inoculation.
Topics: Accidents, Occupational; Adrenergic Agonists; Adrenergic Antagonists; Epinephrine; Female; Fingers; | 2011 |
Use of phentolamine in the treatment of Epipen induced digital ischaemia.
Topics: Accidents, Home; Adrenergic alpha-Antagonists; Adult; Epinephrine; Female; Humans; Ischemia; Phentol | 2012 |
Renalase protects against ischemic AKI.
Topics: Acute Kidney Injury; Adrenergic alpha-Antagonists; Animals; Apoptosis; Gene Expression; Humans; Infl | 2013 |
Dissociation between skeletal muscle microvascular PO2 and hypoxia-induced microvascular inflammation.
Topics: Abdominal Muscles; Animals; Antihypertensive Agents; Blood Pressure; Endothelium, Vascular; Hypotens | 2003 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Adrenaline-induced digital ischaemia reversed with phentolamine.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Autonomic Nerve Block; Epinephrine; | 2006 |
The EpiPen and the ischaemic finger.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Epinephrine; Female; Finger Injuries | 2007 |
[Adrenergic blockade and vascular blood flow in diabetes].
Topics: Adolescent; Adult; Blood Circulation; Diabetes Mellitus; Diabetic Angiopathies; Foot; Humans; Ischem | 1980 |
Correct treatment for accidental epinephrine auto-injector-induced digital ischemia.
Topics: Accidents; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Epinephrine; Fingers; Humans; Is | 1995 |
Accidental epinephrine auto-injector-induced digital ischemia reversed by phentolamine digital block.
Topics: Adult; Epinephrine; Humans; Injections, Subcutaneous; Ischemia; Lidocaine; Male; Needlestick Injurie | 1995 |
Evaluation of the reperfusion syndrome after liver ischemia in the rat.
Topics: Animals; Dopamine; Epinephrine; Hypertension, Pulmonary; Ischemia; Liver; Male; Norepinephrine; Phen | 1996 |
Local injection of phentolamine to treat digital ischaemic necrosis in Raynaud's syndrome.
Topics: Aged; Autonomic Nerve Block; Humans; Ischemia; Male; Necrosis; Phentolamine; Raynaud Disease; Sympat | 1997 |
Treatment of accidental digital injection of adrenaline from an auto-injector device.
Topics: Adrenergic alpha-Antagonists; Epinephrine; Fingers; Humans; Ischemia; Needlestick Injuries; Phentola | 1997 |
Accidental digital injection of adrenaline from an autoinjector device.
Topics: Accidents, Occupational; Adrenergic alpha-Antagonists; Adult; Anesthetics, Local; Epinephrine; Finge | 1998 |
Accidental digital injection of adrenaline from an autoinjector device.
Topics: Adrenergic alpha-Antagonists; Adult; Epinephrine; Female; Fingers; Humans; Ischemia; Needlestick Inj | 1998 |
Liver ischemia modifies the concentration of plasmatic catecholamines after reperfusion in the rat.
Topics: Animals; Catecholamines; Dopamine; Epinephrine; In Vitro Techniques; Ischemia; Liver; Male; Muscle C | 1999 |
Heparin/phentolamine does not improve kidney perfusion with HTK solution after prolonged warm ischemia in a rat non-heart-beating donor model.
Topics: Animals; Glucose; Heart Arrest; Heparin; Ischemia; Kidney; Liver Circulation; Mannitol; Microcircula | 2000 |
Extracorporeal membrane oxygenation support of donor abdominal organs in non-heart-beating donors.
Topics: Adrenergic alpha-Antagonists; Adult; Anticoagulants; Catheterization; Cryotherapy; Diuretics, Osmoti | 2000 |
Epinephrine-induced digital ischemia relieved by phentolamine.
Topics: Accidents, Occupational; Adrenergic alpha-Antagonists; Epinephrine; Female; Humans; Ischemia; Needle | 2001 |
Effect of adrenergic agonists and antagonists on renin release.
Topics: Adrenergic Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic Antagonists | 2001 |
[Role of nitroglycerin for injection in comparison with other vasodilators in the treatment of cardiac failure of ischemic origin].
Topics: Blood Pressure; Coronary Disease; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; | 1979 |
[Renal toxicity of contrast media. Experimental study on dogs (author's transl)].
Topics: Acetrizoic Acid; Animals; Contrast Media; Dogs; Iatrogenic Disease; Ischemia; Kidney Cortex; Kidney | 1976 |
Cyclic AMP and adenylate cyclase in the inner ear.
Topics: Action Potentials; Adenosine Triphosphatases; Adenylyl Cyclases; Animals; Barbiturates; Brain; Bucla | 1975 |
Effect of I-Sar-8-Ala angiotensin II, phentolamine, and PGE1 on the hypotensive ischemic dog kidney under hypothermic pulsatile perfusion.
Topics: Angiotensin II; Animals; Dogs; Female; Ischemia; Kidney; Kidney Function Tests; Kidney Transplantati | 1977 |
Kidney preservation: experimental studies.
Topics: Blood Urea Nitrogen; Creatinine; Hypothermia, Induced; Ischemia; Kidney; Kidney Transplantation; Nep | 1977 |
Treatment of ischaemia after radial artery cannulation.
Topics: Arm; Catheterization; Female; Hand; Humans; Ischemia; Middle Aged; Phentolamine | 1977 |
Characterization of the postocclusive response of renal blood flow in the cat.
Topics: Adenosine; Angiotensin II; Animals; Blood Flow Velocity; Cats; Indomethacin; Ischemia; Kidney; Meclo | 1978 |
Effect of phentolamine on perfusate flow characteristics during renal preservation.
Topics: Animals; Cold Temperature; Dogs; Female; Ischemia; Kidney; Kidney Transplantation; Male; Organ Prese | 1976 |
Neurogenic influences on the coronary vascular response to ischemia in the awake dog.
Topics: Animals; Autonomic Nervous System; Blood Pressure; Constriction; Coronary Circulation; Coronary Vess | 1975 |
Treatment of accidental digital injection of epinephrine.
Topics: Adult; Epinephrine; Female; Fingers; Food Hypersensitivity; Humans; Injections, Subcutaneous; Ischem | 1991 |
Epinephrine-induced vasospasm reversed by phentolamine digital block.
Topics: Accidents; Adolescent; Emergencies; Epinephrine; Finger Injuries; Fingers; Humans; Ischemia; Male; P | 1990 |
Role of noradrenaline in the pathogenesis of skin flap ischemic necrosis in the pig.
Topics: Animals; Ischemia; Necrosis; Norepinephrine; Phenoxybenzamine; Phentolamine; Propranolol; Skin; Surg | 1990 |
Accidental intra-arterial injection of epinephrine treated with phentolamine.
Topics: Epinephrine; Humans; Injections, Intra-Arterial; Ischemia; Male; Middle Aged; Phentolamine | 1989 |
Treatment of peripheral ischemia secondary to lidocaine containing epinephrine.
Topics: Animals; Epinephrine; Foot; Ischemia; Labetalol; Lidocaine; Models, Biological; Necrosis; Phentolami | 1989 |
Local renal ischemia during burn shock in rat effected by thromboxane A2 and serotonin.
Topics: Animals; Blood Pressure; Burns; Indomethacin; Ischemia; Ketanserin; Kidney Cortex; Male; Phentolamin | 1986 |
Acute management of dopamine infiltration injury with Regitine.
Topics: Administration, Topical; Dopamine; Extravasation of Diagnostic and Therapeutic Materials; Hand; Huma | 1987 |
Chemically induced vasospasm: the effect of ischemia, vessel occlusion, and adrenergic blockade.
Topics: Animals; Femoral Artery; Ischemia; Leg; Ligation; Male; Norepinephrine; Phentolamine; Rats; Rats, In | 1985 |
Phentolamine for vasodilator treatment of severe heart-failure.
Topics: Adrenergic alpha-Antagonists; Adult; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Humans; I | 1971 |
Mechanisms of intrarenal hemodynamic changes following acute arterial occlusion.
Topics: Angiotensin II; Animals; Blood Pressure; Diphenhydramine; Dogs; Epinephrine; Hemodynamics; Histamine | 1963 |
Tourniquet poditis--an experimental pedal inflammation in the rat.
Topics: Animals; Anti-Bacterial Agents; Chlorpromazine; Cyproheptadine; Depression, Chemical; Dextrans; Dibe | 1969 |
Pathogenesis of redistribution of intrarenal blood flow in haemorrhagic hypotension.
Topics: Acetylcholine; Angiotensin II; Animals; Autoradiography; Blood Flow Velocity; Dogs; Hypotension; Isc | 1971 |
Arteriovenous fistulae in rabbit kidney studied by dye-dilution technique and by angiography.
Topics: Anesthesia, Intravenous; Aneurysm; Angiography; Angiotensin II; Animals; Arteriovenous Fistula; Bloo | 1972 |
Treatment of pregnancy toxaemia with alpha-blocking agents.
Topics: Adrenergic alpha-Antagonists; Adult; Brain; Capillary Permeability; Eclampsia; Female; Humans; Hyper | 1971 |
Optimal management of warm ischemic kidneys prior to hypothermic preservation.
Topics: Allopurinol; Animals; Cadaver; Cold Temperature; Diuretics; Dogs; Humans; Ischemia; Kidney; Kidney T | 1974 |
Effects of intra-arterial phentolamine in experimental intestinal ischaemia in the rabbit.
Topics: Animals; Aorta, Abdominal; Blood Pressure; Female; Hypotension; Ileum; Injections, Intra-Arterial; I | 1973 |
A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure.
Topics: Adult; Aged; Dilatation; Epinephrine; Forearm; Heart Failure; Humans; Hyperemia; Ischemia; Middle Ag | 1974 |
[Rejection of renal homografts. Elimination of an aspecific component by means of an aspecific adrenergic block].
Topics: Animals; Dogs; Histocompatibility; Ischemia; Kidney; Kidney Transplantation; Phentolamine; Transplan | 1968 |
Renal failure in the patient with cirrhosis. The role of active vasoconstriction.
Topics: Adult; Aged; Angiography; Blood Flow Velocity; Blood Pressure; Brain Diseases; Constriction; Creatin | 1970 |
[Role of ischemia in the pathogenesis of after-angiographic kidney damages. Experimental studies].
Topics: Angiography; Animals; Contrast Media; Dogs; Ischemia; Kidney; Phentolamine; Renal Artery | 1968 |
Ischemia of the hand secondary to levarterenol bitartrate extravasation. Methods of management.
Topics: Female; Hand; Humans; Ischemia; Male; Necrosis; Norepinephrine; Phentolamine; Skin Manifestations; S | 1966 |